Showing 20 of 41 recruiting trials for “microcystic-stromal-tumor”
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
👨⚕️ Howard Colman, MD, PhD, Huntsman Cancer Institute/ University of Utah📍 8 sites📅 Started Jul 2023View details ↗
The Efficacy and Safety of Temozolomide in SDH-deficient GIST
RecruitingNCT05867901 ↗
Clinical Research of Drug Holiday Based on MRD Detection in GIST Patients at High Risk of Recurrence
RecruitingNCT05938309 ↗
A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal Tumors
RecruitingNCT05804331 ↗
The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST
5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
RecruitingNCT05461664 ↗
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA
👨⚕️ Xinhua Zhang, PhD, First affiliated hosptial,Sun Yat-sen university📍 1 site📅 Started Jul 2022View details ↗
RecruitingNCT05464875 ↗
A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors
👨⚕️ Xinhua Zhang, PhD, First affiliated hosptial,Sun Yat-sen university📍 1 site📅 Started Jul 2022View details ↗
RecruitingNCT05440357 ↗
Second-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: A Real-world Study
👨⚕️ zhang xinhua, PhD, First affiliated hosptial,Sun Yat-sen university📍 8 sites📅 Started Jul 2022View details ↗
A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments
Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)
RecruitingNCT05408897 ↗
Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD
Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors
The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
RecruitingNCT03602092 ↗
Observational Registry Data on GIST Patients
👨⚕️ Tsang-Wu Liu, M.D, Taiwan Cooperation Organization Group,NHRI,Taiwan📍 1 site📅 Started Oct 2018View details ↗
RecruitingNCT03716089 ↗
Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site
A Study of HQP1351 in Patients With GIST or Other Solid Tumors
RecruitingNCT04648462 ↗
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →